| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 0 | 0 | 369.860 | 230.894 |
| Total Income - EUR | - | - | - | - | - | 0 | 0 | 0 | 369.860 | 230.940 |
| Total Expenses - EUR | - | - | - | - | - | 130 | 622 | 612 | 285.150 | 188.581 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -130 | -622 | -612 | 84.710 | 42.359 |
| Net Profit/Loss - EUR | - | - | - | - | - | -130 | -622 | -612 | 81.381 | 35.577 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Bioterapeutic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 72 | 0 | 0 | 0 | 3.495 |
| Current Assets | - | - | - | - | - | 2.053 | 1.529 | 871 | 99.865 | 77.604 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 37.061 | 29.181 |
| Receivables | - | - | - | - | - | 6 | 11 | 82 | 49.229 | 40.729 |
| Cash | - | - | - | - | - | 2.047 | 1.518 | 790 | 13.575 | 7.694 |
| Shareholders Funds | - | - | - | - | - | 1.937 | 1.273 | 665 | 82.044 | 37.990 |
| Social Capital | - | - | - | - | - | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | - | - | - | 188 | 256 | 207 | 17.821 | 43.176 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Bioterapeutic S.r.l.